RFRP3(human) acetate(311309-27-0 free base) NEW
| Price | $80 | $181 | $272 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-10-23 |
Product Details
| Product Name: RFRP3(human) acetate(311309-27-0 free base) | Purity: 97.09% |
| Supply Ability: 10g | Release date: 2025/10/23 |
Product Introduction
Bioactivity
| Name | RFRP3(human) acetate(311309-27-0 free base) |
| Description | RFRP-3(human) acetate, a human GnIH peptide homolog, is a potent inhibitor of gonadotropin secretion by inhibiting Ca2+ mobilization. RFRP-3(human) acetate is a NPFF1 receptor agonist, it inhibits forskolin-induced production of cAMP with an IC50 of 0.7 nM. |
| In vitro | RFRP-3(human) acetate efficiently inhibits forskolin-induced production of cAMP with an IC50 of 0.7 nM. Scatchard-plot analysis shows that 125I-labelled hRFRP-3 has a single class of high-affinity binding sites for the membrane fractions of CHO cells expressing rat OT7T022, the Kd value and the Bmax values are 0.19 nM and 1.3 pM, respectively. RFRP-3(human) acetate specifically stimulate cells transfected with a new orphan 7TMR, OT7T022, it binds to OT7T022 as a specific ligand with high affinity (Kd= 0.19 nM)[1]. |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | RFRP-3(human) acetate(311309-27-0 free base) | RFRP3(human) acetate(311309270 free base) | RFRP3(human) acetate(311309 27 0 free base) | RFRP3 acetate(311309-27-0 free base) | NPFF1 | NeuropeptideYReceptor | Neuropeptide Y Receptor |
| Inhibitors Related | AC-263093 | RFRP-1 (human) acetate(311309-25-8 free base) | RF9 acetate | Neuropeptide FF acetate(99566-27-5 free base) | AC-099 hydrochloride | Neuropeptide SF(mouse,rat) acetate |
| Related Compound Libraries | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Peptide Compound Library | Inhibitor Library | NO PAINS Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $50.00/5mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-11-10 | |
| $0.00/25KG |
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-05-16 | |
| $0.00/1kg |
VIP6Y
|
Zison Pharmaceutical (Shandong) Co., Ltd.
|
2024-05-24 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY